obs & gyne. agenda. tahlak, ceo, latifa hospital, dubai, uae 15:25 new fda warning against...

17
28-31 January 2019 The Conrad Hotel Obs & Gyne. Agenda. 25.75 CME points.

Upload: trinhquynh

Post on 07-Apr-2019

229 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

ahcongress.com

28-31 January 2019 � The Conrad Hotel

Obs & Gyne.Agenda.

25.75 CME points.

Page 2: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Theme: ‘Practical guidelines for the 21st century OBGYN practitioner’

What’s new: • NEW VENUE: The Obs & Gyne Conference will be held at the Conrad Hotel to improve your

experience!

• Introduction of dedicated oral and poster presentations, enabling forefront research and

emerging developments to be shared

• Facilitated Imaging masterclass with renowned experts

• Case discussion sessions giving you more opportunities for applied learning

• Reduced price and special rates are now available for Allied Healthcare Professionals*

Key topics: • Recurrent miscarriages: recent guidelines in management

• New FDA warning against vaginal rejuvenation

• Controversial foetal ultrasound findings: what to do?

• Modern surgical and medical management of endometrial cancer

• Hypertensive disorders of pregnancy: ISSHP Classification

• Twin pregnancy: cases and lessons to learn

• Foetal cardiovascular anomalies: cases and lessons to learn

• Updates in hereditary ovarian and breast cancer

• Complications in laparoscopic surgery: can we avoid?

• Developing practical guidelines in reproductive health

• Debate: Management of unexplained infertility

Who should attend: • Gynaecologists

• Obstetricians

• Heads of the Obstetrics & Gynaecology

• Ob-Gyn Consultants / Specialists

• Directors of Maternity Hospitals

• Infertility Specialists

• Foetal-Maternal Medicine Specialists

• Reproductive Medicine Specialists

• Gynaecological Oncologists

Benefits of attending: • Classify vaccines which are indicated in pregnancy for high risk conditions

• Identify and explain the latest trends in research, methods, and technology in the

treatment of gynaecologic cancers

• Debate the impact of maternal factors on egg competence for maintenance of early

pregnancy

• Discuss the indications, techniques, management and prevention of complications of

Urogynaecology surgery

*Allied Healthcare Professionals such as Nurses, Physiotherapists, Radiographers and Technicians can contact the Arab Health conference team on +971 4 336 7334 or [email protected] to find out more about the special rates. Valid company/employee identification with job designation will be required to avail the special rates.

Obs & Gyne Conference.28 - 31 January 2019, The Conrad Hotel, Dubai, UAE. NEW VENUE!

Page 3: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Programme highlights:

Dr Carol Benson, Director of Ultrasound; Co-Director of High Risk Obstetrical Ultrasound

Radiology; Director of the Non-invasive Vascular Laboratory, Brigham & Women’s Hospital;

Professor, Harvard Medical School, Boston, Massachusetts, USA

Management of vulvar dysplasia

Dr Amanda Nickles Fader, Director of the Kelly Gynecologic Oncology Service; Associate Professor

of Gynecology and Obstetrics, Johns Hopkins Medicine, Baltimore, Maryland, USA

Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation

Council for Continuing Medical Education (ACCME) to provide continuing medical education for

physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a

commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American

Osteopathic Association for Category 2 credit.

First trimester assessment of foetal anatomy

Obs & Gyne Conference.28 - 31 January 2019, The Conrad Hotel, Dubai, UAE. NEW VENUE!

Screening for gestational Diabetes Mellitus

Prof Mathew Sermer, Professor of Obstetrics and Gynaecology, University of Toronto; Chief of

Obstetrics & Gynaecology and Medical Lead of the Women’s & Infants’ Centre of Excellence, Head

of the Medical Disorders of Pregnancy Program, Mount Sinai Hospital, Toronto, Canada

maximum of 25.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit

Page 4: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Day one | Monday, 28 January 2019.

08:00 Welcome coffee

09:00 Opening remarks

Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of Obstetrics

and Gynecology Department, Tawam Hospital, Al Ain, UAE

Session 1: General O&G I Moderators: Dr Saleema Wani, Chair of Obstetrics, Corniche Hospital, Abu Dhabi, UAE

Dr Muna Tahlak, CEO, Latifa Hospital, Dubai, UAE

09:05 Are all ectopic pregnancies the same?

Dr Ghada Salman, Consultant: Gynaecology and early pregnancy, University College

London Hospital, London, UK

09:55 Oxytocin in PPH - time to retire?

Dr Saleema Wani, Chair of Obstetrics, Corniche Hospital, Abu Dhabi, UAE

10:20 Interventional Radiology in O&G Dr Jamal Alkoteesh, Consultant Interventional Radiologist; Chairman - Clinical Imaging Institute, Al Ain Hospital, Al Ain, UAE

10:45 PCOS in adolescent - is it different?

Dr Faysal El Kak, Vice President, FIGO; Associate: Women’s Health Centre, Department of

Obstetrics & Gynecology, American University of Beirut Medical Centre, Beirut, Lebanon

11:10 Protect your revenue and optimise insurance reimbursement

Dr Teodora Elena Ucenic, HOD - Consultant OB-GYN, NMC Speciality Hospital, Al Ain, UAE

11:35 Enhanced recovery protocol Dr Habibeh Gitiforooz, Obstetrician-Gynecologist: Regional Obstetrics and Gynecology,

Cleveland Clinic, Cleveland, Ohio, USA

11:50 Lunch break and visit exhibition

Session 2: General O&G II Moderators: Dr Faysal El Kak, Vice President, FIGO; Associate: Women’s Health Centre,

Department of Obstetrics & Gynecology, American University of Beirut Medical Centre, Beirut,

Lebanon

Dr Teodora Elena Ucenic, HOD - Consultant OB-GYN, NMC Speciality Hospital, Al Ain, UAE

13:50 Tips and tricks for safe hysterectomies

Dr Habibeh Gitiforooz, Obstetrician-Gynecologist: Regional Obstetrics and Gynecology,

Cleveland Clinic, Cleveland, Ohio, USA

14:15 Pre-conception is the zero trimester of pregnancy

Dr Faysal El Kak, Vice President, FIGO; Associate: Women’s Health Centre, Department of

Obstetrics & Gynecology, American University of Beirut Medical Centre, Beirut, Lebanon

14:40 Caesarean section at full dilatation

Dr Zainab Shaban, Ob-Gyn, Tawam Hospital, Al Ain, UAE

15:05 Update in pain management in Obstetrics

Dr Rafael Blanco, Consultant Anaesthetist, Kings College Hospital, Dubai, UAE

09:30 All women need immunisation in pregnancy? Dr

Muna Tahlak, CEO, Latifa Hospital, Dubai, UAE

Page 5: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

15:25 New FDA warning against vaginal rejuvenation

Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health Centre, Department of

Obstetrics & Gynecology, American University of Beirut Medical Centre, Beirut, Lebanon

15:45 Coffee break

Session 3: Imaging in O&G Moderator: Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of

Obstetrics and Gynecology Department, Tawam Hospital, Al Ain, UAE

16:30 Imaging masterclass

Content will cover:

• U/S of ovarian masses

• U/S of uterine tumors

• 3D ultrasound in Obstetrics

• U/S of ectopic pregnancy

Facilitators:

- Dr Carol Benson, Director of Ultrasound; Co-Director of High Risk Obstetrical

Ultrasound Radiology; Director of the Non-invasive Vascular Laboratory, Brigham &

Women’s Hospital; Professor, Harvard Medical School, Boston, Massachusetts, USA

- Dr Peter Doubilet, Senior Vice Chair of Radiology, Brigham & Women’s Hospital;

Professor of Radiology, Harvard Medical School, Boston, Massachusetts, USA

18:00 End of day one

Page 6: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Day two | Tuesday, 29 January 2019.

08:00 Welcome coffee

08:20 Opening remarks

Prof Hisham Mirghani, Middle East Ambassador, International Society of Ultrasound in

Obstetrics & Gynecology (ISUOG); Consultant OBGYN/Fetal Medicine, Danat Al Emarat

Hospital for Women & Children, Abu Dhabi, UAE

Dr Bashir Taha Salih, Consultant & Chair of Obstetric Medicine, Corniche Hospital, Abu

Dhabi, UAE

Session 4: Maternal-foetal medicine I Moderators: Dr Bashir Taha Salih, Consultant & Chair of Obstetric Medicine, Corniche Hospital, Abu

Dhabi, UAE

Prof Hisham Mirghani, Middle East Ambassador, International Society of Ultrasound in Obstetrics

& Gynecology (ISUOG); Consultant OBGYN/Fetal Medicine, Danat Al Emarat Hospital for Women &

Children, Abu Dhabi, UAE

08:30 Ultrasound of the placenta and cervix

Dr Carol Benson, Director of Ultrasound; Co-Director of High Risk Obstetrical Ultrasound

Radiology; Director of the Non-invasive Vascular Laboratory, Brigham & Women’s Hospital;

Professor, Harvard Medical School, Boston, Massachusetts, USA

08:55 Peripartum management of women with cardiac disease

Dr Rohan D'Souza, Maternal-Fetal Medicine Physician, Mount Sinai Hospital; Clinician-

Investigator, Lunenfeld-Tanenbaum Research Institute; Assistant Professor, Obstetrics and

Gynaecology, University of Toronto, Toronto, Canada

09:20 First trimester assessment of foetal anatomy

Dr Carol Benson, Director of Ultrasound; Co-Director of High Risk Obstetrical Ultrasound

Radiology; Director of the Non-invasive Vascular Laboratory, Brigham & Women’s Hospital;

Professor, Harvard Medical School, Boston, Massachusetts, USA

09:45 Controversial foetal ultrasound findings: What to do?

Dr Mohamed Kamal, President, Egyptian Fetal Medicine Foundation; Fetal Medicine

Consultant, Ain Shams University, Cairo, Egypt

10:10 Hypertensive disorders of pregnancy: ISSHP classification

Prof Laura Magee, Professor of Women's Health, King’s College London, London, UK

Session 5: Maternal-foetal medicine II Moderator: Prof Hisham Mirghani, Middle East Ambassador, International Society of Ultrasound in

Obstetrics & Gynecology (ISUOG); Consultant OBGYN/Fetal Medicine, Danat Al Emarat Hospital for

Women & Children, Abu Dhabi, UAE

10:35 Twin pregnancy: cases and lessons to learn

Dr Leanne Bricker, Consultant & Chair of Fetal Medicine, Corniche Hospital, Abu Dhabi,

UAE

11:00 Foetal cardiovascular anomalies: cases and lessons to learn

Dr Werner Diehl, Consultant in Fetal Medicine, Corniche Hospital, Abu Dhabi, UAE

11:25 Discussion and Q&A

11:35 Lunch break and visit exhibition

Page 7: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Session 6: Maternal-foetal medicine III Moderators: Dr Leanne Bricker, Consultant & Chair of Fetal Medicine, Corniche Hospital, Abu

Dhabi, UAE

Dr Bashir Taha Salih, Consultant & Chair of Obstetric Medicine, Corniche Hospital, Abu Dhabi, UAE

13:35 Screening for gestational diabetes – a review of current recommendations and

guidelines

Dr Rohan D'Souza, Maternal-Fetal Medicine Physician, Mount Sinai Hospital; Clinician-

Investigator, Lunenfeld-Tanenbaum Research Institute; Assistant Professor, Obstetrics and

Gynaecology, University of Toronto, Toronto, Canada

14:00 Ultrasound assessment of multiple pregnancy Dr Peter Doubilet, Senior Vice Chair of Radiology, Brigham & Women’s Hospital; Professor

of Radiology, Harvard Medical School, Boston, Massachusetts, USA

14:25 Non-immune hydrops: A stepwise management

Dr Mohamed Kamal, President, Egyptian Fetal Medicine Foundation; Fetal Medicine

Consultant, Ain Shams University, Cairo, Egypt

14:50 Coffee break

Session 7: Maternal-foetal medicine IV Moderators: Dr Saleema Wani, Chair of Obstetrics, Corniche Hospital, Abu Dhabi, UAE

Dr Werner Diehl, Consultant in Fetal Medicine, Corniche Hospital, Abu Dhabi, UAE

15:30 Placental markers for preeclampsia & IUGR

Prof Laura Magee, Professor of Women's Health, King’s College London, London, UK

15:55 Foetal skeletal assessment: how and why to perform?

Prof Hisham Mirghani, Middle East Ambassador, International Society of Ultrasound in

Obstetrics & Gynecology (ISUOG); Consultant OBGYN/Fetal Medicine, Danat Al Emarat

Hospital for Women & Children, Abu Dhabi, UAE

16:20 First trimester screening: how and why to perform?

Dr Muzib Begam, Consultant: Obstetric/Fetal-Maternal Medicine, Mediclinic, Abu Dhabi,

UAE

16:40 AFL-monitoring (Amniotic Fluid Lactate), a new method for treating woman with

prolonged labour

Dr Eva Wiberg-Itzel, Assistant Prof: Department of Clinical Science and Education,

Karolinska Institute, South Hospital, Stockholm, Sweden

17:00 A rare case of brain tumour in pregnancy: What do you know?

Dr Omaema Al Baghdadi, Obs & Gyne Consultant, Tawam Hospital, Al Ain, UAE

Session 8: Oral abstract presentations Moderators: Dr Rohan D'Souza, Maternal-Fetal Medicine Physician, Mount Sinai Hospital; Clinician-Investigator, Lunenfeld-Tanenbaum Research Institute; Assistant Professor, Obstetrics and Gynaecology, University of Toronto, Toronto, Canada Prof Laura Magee, Professor of Women's Health, King’s College London, London, UK

17:20 Fetal cardiology: Indication and impact on post-natal outcome Dr Mohamed Sulaiman, Consultant Fetal & Paediatric Cardiologist, KidsHeart Medical Centre, Abu Dhabi, UAE

17:30 Cardiac disease: Pregnancy outcomes over a decade Dr Fathima Farook, Specialist: Obstetrics Medicine, Corniche Hospital, Al Ain, UAE

17:40 Obstetric critical care Dr Hala Abuzeid Ahmed, Critical Care Consultant, Mafraq Hospital, Abu Dhabi, UAE

Page 8: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

17:50 Atypical Pre-Eclampsia in a patient with a past history of venous thromboembolism Dr Hessa A Swaidi, O&G Resident, Obstetric Medicine Unit, Corniche Hospital, Al Ain, UAE

18:00 End of day two

Page 9: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Day three | Wednesday, 30 January 2019.

08:00 Welcome coffee

08:20 Opening remarks

Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of Obstetrics

and Gynecology Department, Tawam Hospital, Al Ain, UAE

Session 9: Women’s oncology I Moderator: Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of

Obstetrics and Gynecology Department, Tawam Hospital, Al Ain, UAE

08:30 Management of vulvar dysplasia

Dr Rebecca Stone, Assistant Professor: Obstetrics & Gynaecology, Kelly Gynaecologic

Oncology Service, Johns Hopkins Medicine, Baltimore, Maryland, USA

08:55 Vulvar and vaginal cancer standard of care and innovation

Dr Colleen Feltmate, Director, Minimally Invasive Surgery in Gynecologic Oncology,

Brigham and Women's Hospital; Assistant Professor of Obstetrics, Gynecology and

Reproductive Biology, Harvard Medical School, Boston, Massachusetts, USA

09:20 Updates in hereditary ovarian and breast cancer

Dr Hassan Jaafar, Hemato-Oncology Consultant, Oncology Center, Sheikh Khalifa Specialty

Hospital, Ras al-Khaimah, UAE

09:45 Management of endometrial hyperplasia with and without Atypia

Dr Rebecca Stone, Assistant Professor: Obstetrics & Gynaecology, Kelly Gynaecologic

Oncology Service, Johns Hopkins Medicine, Baltimore, Maryland, USA

10:10 Modern surgical and medical management of endometrial cancer

Dr Colleen Feltmate, Director, Minimally Invasive Surgery in Gynecologic Oncology,

Brigham and Women's Hospital; Assistant Professor of Obstetrics, Gynecology and

Reproductive Biology, Harvard Medical School, Boston, Massachusetts, USA

10:35 Coffee break

Session 10: Women’s oncology II Moderators: Dr Rebecca Stone, Assistant Professor: Obstetrics & Gynaecology, Kelly Gynaecologic Oncology Service, Johns Hopkins Medicine, Baltimore, Maryland, USA Dr Asif Quadri, Consultant - Anatomical Pathology, Tawam Hospital, Al Ain, UAE 11:20 Importance of tumour grading and cell type in gynaecologic cancer management

Dr Asif Quadri, Consultant - Anatomical Pathology, Tawam Hospital, Al Ain, UAE

11:40 Management of adnexal mass

Dr Thikra Hassan, OB-GYN & Chief of Gynecology Division, Tawam Hospital, Al Ain, UAE

12:00 Global paradigm shift in cervical cancer prevention

Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of Obstetrics

and Gynecology Department, Tawam Hospital, Al Ain, UAE

Page 10: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

12:20 Tumour board: case discussions

Moderator: Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of

Obstetrics and Gynecology Department, Tawam Hospital, Al Ain, UAE

Panellists:

- Dr Rebecca Stone, Assistant Professor: Obstetrics & Gynaecology, Kelly

Gynaecologic Oncology Service, Johns Hopkins Medicine, Baltimore, Maryland, USA

- Dr Colleen Feltmate, Director, Minimally Invasive Surgery in Gynecologic

Oncology, Brigham and Women's Hospital; Assistant Professor of Obstetrics,

Gynecology and Reproductive Biology, Harvard Medical School, Boston,

Massachusetts, USA

- Dr Hassan Jaafar, Hemato-Oncology Consultant, Oncology Center, Sheikh Khalifa

Specialty Hospital, Ras al-Khaimah, UAE

- Dr Thikra Hassan, OB-GYN & Chief of Gynecology Division, Tawam Hospital, Al Ain,

UAE

13:00 Lunch break and visit exhibition

Session 11: Urogynaecology/gyne-endoscopy Moderators: Dr Sadoon Sadoon, Medical Director, Danat Al Emarat Women & Children’s Hospital,

Abu Dhabi, UAE

Dr Azar Khunda, Consultant Urogynaecologist & Obstetrician, Guy's and St Thomas' NHS

Foundation Trust, London, UK

15:00 Endometriosis management update

Dr Arnaud Wattiez, Prof: Obstetrics & Gynecology, University of Strasbourg; Head:

Gynecology Department, Latifa Hospital, Dubai, UAE

15:20 Overactive bladder - how to approach?

Dr Azar Khunda, Consultant Urogynaecologist & Obstetrician, Guy's and St Thomas' NHS

Foundation Trust, London, UK

15:40 Ambulatory gynaecology: the role of office hysteroscopy

Dr Ghada Salman, Consultant: Gynaecology and early pregnancy, University College

London Hospital, London, UK

16:00 Gynaecologist view on the management of vaginal vault prolapse

Dr Omaema Al Baghdadi, Obs & Gyne Consultant, Tawam Hospital, Al Ain, UAE

Session 12: Urogynaecology/Gyne-endoscopy II Moderators: Dr Habibeh Gitiforooz, Obstetrician-Gynecologist: Regional Obstetrics and

Gynecology, Cleveland Clinic, Cleveland, Ohio, USA

Dr Amithaba Majumder, Consultant: Department of Ob/Gyn, Corniche Hospital, Abu Dhabi, UAE

16:20 Mesh or no mesh?

Dr Amithaba Majumder, Consultant: Department of Ob/Gyn, Corniche Hospital, Abu Dhabi,

UAE

16:40 Non-mesh surgery for stress incontinence

Dr Azar Khunda, Consultant Urogynaecologist & Obstetrician, Guy's and St Thomas' NHS

Foundation Trust, London, UK

17:00 To morcellate or not?

Dr Sadoon Sadoon, Medical Director, Danat Al Emarat Women & Children’s Hospital, Abu

Dhabi, UAE

Page 11: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Session 13: Oral abstract presentations Moderators: Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of

Obstetrics and Gynecology Department, Tawam Hospital, Al Ain, UAE

17:20 Randomised control trial for weekly methotrexate composed with bday methotrexate- folinic acid regimen for low-risk gestational trophoblastic neoplasia

Prof Khalid Sait, Director - Gynaecology Oncology, King Abdulaziz University, Jeddah, KSA

17:30 Cancer cervix staging in Saudi Arabia: Clinic-Radiological correlation Prof Nisreen Anfinan, Associate Professor - Gynecology Oncology, King Abdulaziz

University, Jeddah, KSA

18:00 End of day three

Page 12: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Day four | Thursday, 31 January 2019.

08:00 Welcome coffee

08:20 Opening remarks

Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive Medicine, Dubai

Gynaecology and Fertility Centre (DGFC), Dubai, UAE

Session 14: Reproductive medicine I Moderators: Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive Medicine, Dubai Gynaecology and Fertility Centre (DGFC), Dubai, UAE Dr Tommaso Falcone, Chief of Staff & Chief Academic Officer, Medical Director, Cleveland Clinic London, London, UK

08:30 Developing practical guidelines in reproductive health

Dr Tommaso Falcone, Chief of Staff & Chief Academic Officer, Medical Director, Cleveland

Clinic London, London, UK

08:55 Fertility preservation from the past to the future

Prof Claus Yding Andersen, Professor of Human Reproductive Physiology, The Laboratory

of Reproductive Biology, the Department of Fertility, The Juliane Marie Centre,

Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark

09:20 Ultrasonography and endometrial receptivity

Dr Kannamannadiar Jayaprakasan, Subspecialist and Hon. Associate Professor:

Reproductive Medicine & Surgery, University of Nottingham; Consultant Gynaecologist/

Fertility Lead, Royal Derby Hospital, Derby, UK

09:45 Does androgens augment ovarian response?

Prof Claus Yding Andersen, Professor of Human Reproductive Physiology, The Laboratory

of Reproductive Biology, the Department of Fertility, The Juliane Marie Centre,

Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark

10:10 Ultrasonography from ovarian reserve to follicles’ dynamic

Dr Kannamannadiar Jayaprakasan, Subspecialist and Hon. Associate Professor:

Reproductive Medicine & Surgery, University of Nottingham; Consultant Gynaecologist/

Fertility Lead, Royal Derby Hospital, Derby, UK

10:30 Coffee break

Session 15: Reproductive medicine II Moderator: Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive Medicine, Dubai

Gynaecology and Fertility Centre (DGFC), Dubai, UAE

11:15 Optimising and individualising luteal phase support

Prof Claus Yding Andersen, Professor of Human Reproductive Physiology, The Laboratory

of Reproductive Biology, the Department of Fertility, The Juliane Marie Centre,

Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark

11:40 Tips to gynaecologists who perform ultrasound examination to infertile women

Dr Kannamannadiar Jayaprakasan, Subspecialist and Hon. Associate Professor:

Reproductive Medicine & Surgery, University of Nottingham; Consultant Gynaecologist/

Fertility Lead, Royal Derby Hospital, Derby, UK

Page 13: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

• Introduction and vote: Dr Mohamed Elkalyoubi, Consultant - OBGYN &

Reproductive Medicine, Dubai Gynaecology and Fertility Centre (DGFC), Dubai, UAE

(5min)

• Surgical Approach - Dr Tommaso Falcone, Chief of Staff & Chief Academic Officer,

Medical Director, Cleveland Clinic London, London, UK (15min)

• IVF option - Dr Michael Fakih, Chairman, Founder & Medical Director, Fakih IVF,

NMC Healthcare, Dubai, UAE (15min)

• Conclusion: Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive

Medicine, Dubai Gynaecology and Fertility Centre (DGFC), Dubai, UAE (5min)

12:45 Lunch break and visit exhibition

Session 16: Hot topics in O&G Moderator: Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive Medicine, Dubai

Gynaecology and Fertility Centre (DGFC), Dubai, UAE

14:30 Update on uterus transplant - global & USA experience

Dr Tommaso Falcone, Chief of Staff & Chief Academic Officer, Medical Director, Cleveland

Clinic London, London, UK

14:55 Poor responders in ART Dr Panayota Zarmakoupis, Consultant OB&GYN / Reproductive Endocrinology – IVF Unit, Tawam Fertility Centre, Tawam Hospital, Al Ain, UAE

15:20 Recent guideline in the medical and surgical management of leiomyomas

Dr Ibrahim Abd Elrahman, Consultant Gynaecologist & Assistant Prof - Advanced

Laparoscopic Surgery, MBRU, Dubai, UAE

15:45 Q & A Session Faculty

Session 17: Oral abstract presentations 16:00 Deep infiltrating endometriosis- Single centre experience - Latifa hospital, Dubai Dr Razan Nasir, Gynaecology Specialist, Latifa Hospital, Dubai, UAE

16:15 End of conference

12:05 Debate: Laparoscopic proven endometriosis - conservative surgery vs. IVF

Page 14: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Speaker faculty.

Activity directors:

Dr Habibeh Gitiforooz, Obstetrician-Gynecologist: Regional Obstetrics and Gynecology,

Cleveland Clinic, Cleveland, Ohio, USA

Dr Tommaso Falcone, Chief of Staff & Chief Academic Officer, Medical Director, Cleveland

Clinic London, London, UK

Local chair:

Dr Saad Ghazal-Aswad, Senior Consultant Gynecological Oncologist; Chair of Obstetrics

and Gynecology Department, Tawam Hospital, Al Ain, UAE

Scientific committee:

Dr Bashir Taha Salih, Consultant & Chair of Obstetric Medicine, Corniche Hospital, Abu

Dhabi, UAE

Prof Hisham Mirghani, Middle East Ambassador, International Society of Ultrasound in

Obstetrics & Gynecology (ISUOG); Consultant OBGYN/Fetal Medicine, Danat Al Emarat

Hospital for Women & Children, Abu Dhabi, UAE

Dr Mohamed Elkalyoubi, Consultant - OBGYN & Reproductive Medicine, Dubai

Gynaecology and Fertility Centre (DGFC), Dubai, UAE

Dr Sadoon Sadoon, Medical Director, Danat Al Emarat Women & Children’s Hospital, Abu

Dhabi, UAE

Dr Saleema Wani, Chair of Obstetrics, Corniche Hospital, Abu Dhabi, UAE

Speakers: Dr Amithaba Majumder, Consultant: Department of Ob/Gyn, Corniche Hospital, Abu

Dhabi, UAE

Dr Arnaud Wattiez, Prof: Obstetrics & Gynecology, University of Strasbourg; Head:

Gynecology Department, Latifa Hospital, Dubai, UAE

Dr Asif Quadri, Consultant - Anatomical Pathology, Tawam Hospital, Al Ain, UAE

Dr Azar Khunda, Consultant Urogynaecologist & Obstetrician, Guy's and St Thomas' NHS

Foundation Trust, London, UK

Dr Carol Benson, Director of Ultrasound; Co-Director of High Risk Obstetrical Ultrasound

Radiology; Director of the Non-invasive Vascular Laboratory, Brigham & Women’s

Hospital; Professor, Harvard Medical School, Boston, Massachusetts, USA

Prof Claus Yding Andersen, Professor of Human Reproductive Physiology, The Laboratory

of Reproductive Biology, the Department of Fertility, The Juliane Marie Centre,

Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark

Dr Colleen Feltmate, Director, Minimally Invasive Surgery in Gynecologic Oncology,

Brigham and Women's Hospital; Assistant Professor of Obstetrics, Gynecology and

Reproductive Biology, Harvard Medical School, Boston, Massachusetts, USA

Dr Eva Wiberg-Itzel, Assistant Prof: Department of Clinical Science and Education,

Karolinska Institute, South Hospital, Stockholm, Sweden

Dr Fathima Farook, Specialist: Obstetrics Medicine, Corniche Hospital, Al Ain, UAE

Dr Faysal El Kak, Vice President, FIGO; Associate: Women’s Health Centre, Department of

Obstetrics & Gynecology, American University of Beirut Medical Centre, Beirut, Lebanon

Dr Ghada Salman, Consultant: Gynaecology and early pregnancy, University College

London Hospital, London, UK

Page 15: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Dr Hala Abuzeid Ahmed, Critical Care Consultant, Mafraq Hospital, Abu Dhabi, UAE

Dr Hassan Jaafar, Hemato-Oncology Consultant, Oncology Center, Sheikh Khalifa

Specialty Hospital, Ras al-Khaimah, UAE

Dr Hessa A Swaidi, O&G Resident, Obstetric Medicine Unit, Corniche Hospital, Al Ain, UAE

Dr Ibrahim Abd Elrahman, Consultant Gynaecologist & Assistant Prof - Advanced

Laparoscopic Surgery, MBRU, Dubai, UAE

Dr Jamal Alkoteesh, Consultant Interventional Radiologist; Chairman - Clinical Imaging Institute, Al Ain Hospital, Al Ain, UAE

Dr Kannamannadiar Jayaprakasan, Subspecialist and Hon. Associate Professor:

Reproductive Medicine & Surgery, University of Nottingham; Consultant Gynaecologist/

Fertility Lead, Royal Derby Hospital, Derby, UK

Prof Khalid Sait, Director - Gynaecology Oncology, King Abdulaziz University, Jeddah, KSA

Prof Laura Magee, Professor of Women's Health, King’s College London, London, UK

Dr Leanne Bricker, Consultant & Chair of Fetal Medicine, Corniche Hospital, Abu Dhabi,

UAE

Dr Michael Fakih, Chairman, Founder & Medical Director, Fakih IVF, NMC Healthcare,

Dubai, UAE

Dr Mohamed Kamal, President, Egyptian Fetal Medicine Foundation; Fetal Medicine

Consultant, Ain Shams University, Cairo, Egypt

Dr Mohamed Sulaiman, Consultant Fetal & Paediatric Cardiologist, KidsHeart Medical Centre, Abu Dhabi, UAE

Dr Muna Tahlak, CEO, Latifa Hospital, Dubai, UAE

Dr Muzib Begam, Consultant: Obstetric/Fetal-Maternal Medicine, Mediclinic, Abu Dhabi,

UAE

Prof Nisreen Anfinan, Associate Professor - Gynecology Oncology, King Abdulaziz

University, Jeddah, KSA

Dr Omaema Al Baghdadi, Obs & Gyne Consultant, Tawam Hospital, Al Ain, UAE

Dr Panayota Zarmakoupis, Consultant OB&GYN / Reproductive Endocrinology – IVF Unit, Tawam Fertility Centre, Tawam Hospital, Al Ain, UAE

Dr Peter Doubilet, Senior Vice Chair of Radiology, Brigham & Women’s Hospital;

Professor of Radiology, Harvard Medical School, Boston, Massachusetts, USA

Dr Rafael Blanco, Consultant Anaesthetist, King College Hospital, Dubai, UAE

Dr Razan Nasir, Gynaecology Specialist, Latifa Hospital, Dubai, UAE

Dr Rebecca Stone, Assistant Professor: Obstetrics & Gynaecology, Kelly Gynaecologic

Oncology Service, Johns Hopkins Medicine, Baltimore, Maryland, USA

Dr Rohan D'Souza, Maternal-Fetal Medicine Physician, Mount Sinai Hospital; Clinician-

Investigator, Lunenfeld-Tanenbaum Research Institute; Assistant Professor, Obstetrics

and Gynaecology, University of Toronto, Toronto, Canada

Dr Teodora Elena Ucenic, HOD - Consultant OB-GYN, NMC Speciality Hospital, Al Ain,

UAE

Dr Thikra Hassan, OB-GYN & Chief of Gynecology Division, Tawam Hospital, Al Ain, UAE

Dr Werner Diehl, Consultant in Fetal Medicine, Corniche Hospital, Abu Dhabi, UAE

Dr Zainab Shaban, Ob-Gyn, Tawam Hospital, Al Ain, UAE

Page 16: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

Faculty disclosure: The Cleveland Clinic Foundation Center for Continuing Education has

implemented a policy to comply with the current Accreditation Council for Continuing Medical

Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest.

Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

Page 17: Obs & Gyne. Agenda. Tahlak, CEO, Latifa Hospital, Dubai, UAE 15:25 New FDA warning against vaginal rejuvenation Dr Faysal El Kak, Vice President, FIGO, Associate: Women’s Health

We give you the flexibility to choose the number of days you would like to attend. Please see below the pricing packages for the conferences. Once you have selected the conference and number of days you will be attending, make sure to let us know which dates they will be so we can reserve your place.

Book your conference today!

Payment details.� Payments can be made by either credit card or electronic bank transfer.� A confirmation letter and invoice will be sent to upon receipt of your registration.� Please note that full payment must be received prior to the event. Only those

delegates whose fees have been paid in full will be admitted to the event. ahcongress.com

Three easy ways to register.

Complete the registration form on www.ahcongress.com

Email us at [email protected]

Call us on

Conference packages. Early discount (before 6 Dec).

Regular (before 23 Jan).

Onsite (28-31 Jan)

AED US$ AED US$ AED US$

AAA 4,500 1,225

Obs & Gyne

1-day package 1,200 327 1,500 409 1,800 491

2-day package 2,200 599 2,500 681 2,800 763

3-day package 2,700 735 3,000 817 3,300 899

4-day package 3,000 817 3,300 899 3,600 981

Total Radiology

1-day package 650 177 850 232 1,100 300

2-day package 850 231 1,050 286 1,300 354

3-day package 1,050 286 1,250 341 1,500 409

4-day package 1,350 368 1,550 423 1,800 491

Orthopaedics

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

3-day package 3,000 817 3,200 872 3,500 954

4-day package 3,300 899 3,500 954 3,800 1,035

Surgery

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

3-day package 3,000 817 3,200 872 3,500 954

4-day package 3,300 899 3,500 954 3,800 1,035

Gastroenterology

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

Diabetes

1-day package 1,200 327 1,500 409 1,800 491

2-day package 2,200 599 2,500 681 2,800 763

Paediatrics

1-day package 1,200 327 1,500 409 1,800 491

2-day package 2,200 599 2,500 681 2,800 763

Public Health

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

Anaesthesia

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

Emergency Medicine

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

Quality Management

1-day package 1,600 436 1,800 491 2,100 572

2-day package 2,500 681 2,700 736 3,000 817

+971 4 408 2891